These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2951574)

  • 21. Dopaminergic stimulation of cAMP accumulation in cultured rat mesangial cells.
    Shultz PJ; Sedor JR; Abboud HE
    Am J Physiol; 1987 Aug; 253(2 Pt 2):H358-64. PubMed ID: 3039860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypothalamic D2 receptors mediate the preferential release of somatostatin-28 in response to dopaminergic stimulation.
    Lewis BM; Dieguez C; Lewis M; Hall R; Scanlon MF
    Endocrinology; 1986 Oct; 119(4):1712-7. PubMed ID: 2428601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catecholamine receptors involved in the inhibitory effects of dopamine on vagally stimulated gastric acid secretion and mucosal blood flow in rats.
    Nishikawa H; Yokotani K; Fujiwara M
    J Pharmacol Exp Ther; 1987 Mar; 240(3):966-71. PubMed ID: 3031280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible involvement of dopamine D-1 and D-2 receptors in diazepam-induced hyperphagia in rats.
    Naruse T; Amano H; Koizumi Y
    Fundam Clin Pharmacol; 1991; 5(8):677-93. PubMed ID: 1838347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central dopaminergic origin of bromocriptine induced tachycardia in normotensive rats.
    Lahlou S; Duarte GP; Demenge P
    Cardiovasc Res; 1993 Nov; 27(11):2022-7. PubMed ID: 8287413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine.
    Mereu G; Collu M; Ongini E; Biggio G; Gessa GL
    Eur J Pharmacol; 1985 May; 111(3):393-6. PubMed ID: 3894035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems.
    Sonsalla PK; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1986 Sep; 238(3):932-7. PubMed ID: 2943891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin-stimulated prolactin secretion may not involve the dopaminergic system.
    Tai MH; Teo KL; Pan JT
    Chin J Physiol; 1990; 33(4):345-52. PubMed ID: 2097103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.
    Mele A; Castellano C; Felici A; Cabib S; Caccia S; Oliverio A
    Eur J Pharmacol; 1996 Jul; 308(1):1-12. PubMed ID: 8836626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of brain dopaminergic system in the adrenomedullin-induced diuresis and natriuresis.
    Díaz E; Silva M; Israel A
    Pharmacol Res; 2003 Nov; 48(5):489-96. PubMed ID: 12967595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
    Sesack SR; Bunney BS
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1323-33. PubMed ID: 2564893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible involvement of nigrostriatal dopamine system in the inhibition of thyrotropin secretion in the rat.
    Männistö P; Mattila J; Kaakkola S
    Eur J Pharmacol; 1981 Dec; 76(4):403-9. PubMed ID: 6799305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of D1 and D2 dopamine receptor antagonists on acupuncture analgesia].
    Wang HH; Xu SF
    Sheng Li Xue Bao; 1993 Feb; 45(1):61-8. PubMed ID: 8503031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D-2 dopamine antagonist-like effects of SCH 23390 on A9 and A10 dopamine neurons.
    Goldstein JM; Litwin LC; Sutton EB; Malick JB
    Life Sci; 1987 Mar; 40(11):1039-44. PubMed ID: 2950291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis.
    Imperato A; Di Chiara G
    Eur J Pharmacol; 1988 Nov; 156(3):385-93. PubMed ID: 2905668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals.
    el Mestikawy S; Glowinski J; Hamon M
    J Neurochem; 1986 Jan; 46(1):12-22. PubMed ID: 2866232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of D1 dopamine receptors in the nicotine-induced neuro-endocrine effects and depletion of diencephalic catecholamine stores in the male rat.
    Andersson K; Fuxe K; Eneroth P; Härfstrand A; Agnati LF
    Neuroendocrinology; 1988 Aug; 48(2):188-200. PubMed ID: 2975769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of central and peripheral dopamine antagonism on aldosterone secretion: evidence for adrenal mechanism.
    Stern N; Eggena P; Chandler W; Tuck ML
    Am J Physiol; 1989 Oct; 257(4 Pt 1):E588-94. PubMed ID: 2679132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.